Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Oct;3(5):219-26.
doi: 10.1111/j.1752-8062.2010.00228.x.

Late onset sporadic dilated cardiomyopathy caused by a cardiac troponin T mutation

Affiliations
Case Reports

Late onset sporadic dilated cardiomyopathy caused by a cardiac troponin T mutation

Ana Morales et al. Clin Transl Sci. 2010 Oct.

Abstract

Mutations in TNNT2, encoding cardiac troponin T, commonly shows early onset, aggressive dilated cardiomyopathy (DCM). This observation may influence the decision of whether to undertake clinical genetic testing for TNNT2 in later onset DCM. Further, the trigger for late onset DCM remains enigmatic. A 70-year-old woman, previously healthy with a left ventricular ejection fraction of 50%-55% at age 69, presented with DCM of unknown cause and a 4-month history progressive heart failure requiring cardiac transplantation. Clinical genetic testing revealed a novel TNNT2 R139H mutation but no relevant variants in 18 other DCM genes. Her explanted heart showed partial fatty replacement in the right ventricle. Sequencing for five arrhythmogenic right ventricular dysplasia genes was negative. Functional studies in porcine cardiac skinned fibers reconstituted with the mutant R139H troponin T protein showed decreased Ca(2+) sensitivity at pH 7, characteristic of DCM. Because fatty infiltration may acidify the myocellular environment, maximal force development examined at pH 6.5 was diminished, suggesting a possible environmental trigger. We conclude that the TNNT2 R139H mutation was likely to be disease causing. Further, later age of onset may not be relevant to exclude genetic testing for TNNT2 mutations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Explanted heart. A transverse section of explanted heart at about the proximal third between the atrioventricular groove and apex shows moderate amount of epicardial fat and marked fatty infiltration of the right ventricular wall. There is dilatation of the right ventricular cavity, slight dilatation of the left ventricular cavity, and the left ventricular wall has a normal uniform thickness without myocardial lesions.
Figure 2
Figure 2
Photomicrograph of the right ventricular wall. The extensive fatty infiltration of the myocardium and absence of fibrosis is shown in this trichrome stained section.
Figure 3
Figure 3
Pedigree. Squares represent males; circles represent females. The presence (+) of a troponin T mutation is indicated for those from whom DNA was available. Filled symbols indicate IDC. Gray symbols indicate another form of cardiovascular abnormality or diagnosis. See text for detailed clinical descriptions.
Figure 4
Figure 4
Normalized pCa‐force relationship in skinned cardiac muscle fibers. The Ca2+ dependence of force development was measured in each preparation after whole troponin (Tn) displacement and reconstitution at pH 7.0 and pH 6.5. The maximal force recovery was also evaluated and no significant difference was observed at pH 7.0 between fibers containing wild‐type human cardiac troponin T (HCTnT‐WT) and HCTnT‐R139H (57.4 ± 1.8 vs. 58.9 ± 4.7), respectively. However, a difference in maximal force recovery was observed at pH 6.5 between HCTnT‐WT and HCTnT‐R139H (53.9 ± 2.6 vs. 43.8 ± 2.7), respectively. Data in each experiment are the average of 5 experiments and expressed as mean ± S.E. *=p < 0.05 compared to the HCTnT‐WT.

Similar articles

Cited by

References

    1. Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA. Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. J Card Fail. 2009; 15: 83–97. - PubMed
    1. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 2005; 45: 969–981. - PubMed
    1. Hershberger RE, Cowan J, Morales A, Siegfried JD. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail. 2009; 2: 253–261. - PMC - PubMed
    1. Hershberger RE, Kushner JK, Parks SP. Dilated Cardiomyopathy Overview. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Available at: http://www.genetests.org. Accessed July 10, 2008.
    1. Judge DP, Johnson NM. Genetic evaluation of familial cardiomyopathy. J Cardiovasc Trans Res. 2008; 1: 144–154. - PubMed

Publication types